Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE114.850 (0 %)
PREV CLOSE () 114.85
OPEN PRICE () 114.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7000
TODAY'S LOW / HIGH ()114.85 114.85
52 WK LOW / HIGH () 80160
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2003

Management Info :

Hemant Chandravadan Bhagat - Chairman Hemant Chandravadan Bhagat - Managing Director

Registered Office :

Address : Flat No. 1 & 2, Gr. Floor, 323,F, Bhagat Bhuvan Dr. Ambedkar Road,Matunga (East),
Mumbai,
Maharashtra-400019

Phone : 022-24146154 / 24157205 / 24129162

Website : www.cbcpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS
18Nov Chandra Bhagat Pharma informs about pr
Chandra Bhagat Pharma has informed that the 18th Annual General Meeting..
21Oct Chandra Bhagat Pharma informs about ou
Chandra Bhagat Pharma has informed that the Board of Directors of the Co..
01Oct Chandra Bhagat Pharma informs about cl
In Accordance with code of Internal Procedure and Conduct of Regulating,..
22Jun Chandra Bhagat Pharma informs about bo
Chandra Bhagat Pharma has informed that meeting of the Board of Director..
30Jan Chandra Bhagat Pharma coming with an I
Chandra Bhagat Pharma Chandra Bhagat Pharma is coming out with is coming..
Financials
in Millions
QTR ANNUAL 23
Net Profit9.0400000000001
Gross Profit 11.6100000000001
Operating Profit 36.1400000000001
Net Sales 1196.72
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8598.00 (3.29%)
M.Cap ( in Cr)
19645.12
Abbott India (BSE)
 26637.65 (0.84%)
M.Cap ( in Cr)
56187.09
Amrutanjan Healthcar (BSE)
 764.60 (9.55%)
M.Cap ( in Cr)
2052.94
Dr. Reddy's Lab (BSE)
 6257.65 (0.85%)
M.Cap ( in Cr)
104307.29
Torrent Pharma (BSE)
 2676.60 (1.37%)
M.Cap ( in Cr)
90493.54
Shareholding Pattern
PROMOTERS 68.77%
NON-INSTITUTION 29.01%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74743.48260.70 (0.35%)
NIFTY22695.8591.00 (0.40%)
Dow Jones 37903.2987.37 (0.23%)
Nasdaq 15605.48-52.34 (-0.33%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI